Author: Ken Dropiewski

Dr. Marc H. Glickman to Present at 6th Israeli Vascular Access Conference

IRVINE, Calif., Jan. 15, 2019 (GLOBE NEWSWIRE) — Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a Company specializing in medical devices that restore cardiac and vascular health, today announced that Dr. Marc H. Glickman, HJLI’s Chief Medical Officer, will be presenting at the 6th Israeli Vascular Access Conference in Herzlia, […]

Boston Scientific, Edwards Lifesciences Agree To Global Litigation Settlement

MARLBOROUGH, Mass. and IRVINE, Calif., Jan. 15, 2019 /PRNewswire/ — Boston Scientific Corporation (NYSE:  BSX) and Edwards Lifesciences Corporation (NYSE: EW) today announced that the companies have reached an agreement to settle all outstanding patent disputes between the companies in all venues around the world. All pending cases or appeals in courts and patent offices between […]

Neovasc Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency

VANCOUVER, Jan. 14, 2019 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX:NVCN) announced today that it has received written notification (the “Notification Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Rules for […]

Medtronic Launches Mobile App That Communicates Directly with World’s First Smartphone-Connected Pacemakers

DUBLIN – January 15, 2019 – Medtronic plc (NYSE:MDT) today announced the launch of its MyCareLink Heart(TM) mobile app to support the world’s first and only portfolio of pacemakers that can communicate directly with patients’ smartphones and tablets. Compatible with Medtronic BlueSync(TM) technology-enabled pacemakers, the MyCareLink Heart mobile app is designed […]

Vascular Therapies Appoints John McDermott as Chief Executive Officer

CRESSKILL, N.J., Jan. 9, 2019 /PRNewswire/ — Vascular Therapies, a biotechnology company focused on improving outcomes for patients with advanced kidney disease, today announced the appointment of John McDermott as the Company’s Chief Executive Officer. Bob Croce, Chairman of the Board of Directors of Vascular Therapies, Inc. commented, “We are very pleased to welcome John […]

Shore Capital-Backed IZI Medical Products Announces Acquisition of Quick-Core® Biopsy and Breast Localization Needle Assets from Cook Medical

CHICAGO–(BUSINESS WIRE)–IZI Medical Products, LLC (“IZI”), a leading interventional radiology medical device company and portfolio company of Shore Capital Partners, LLC (“Shore”), is pleased to announce it has acquired select soft tissue biopsy and breast localization needle assets from Cook Medical (“Cook”). The acquired portfolio of products are commercially marketed […]

Euphrates Vascular announces FDA clearance of the ICHOR Reperfusion System 

St. Louis, Missouri – Euphrates Vascular (, a company focused on the treatment of vascular occlusions, recently received 510(k) clearance for sale of its ICHOR Percutaneous Reperfusion System. ICHOR is a Percutaneous Reperfusion System designed to treat organized thrombus and embolic events in the peripheral vasculature. ICHOR is a “one size fits […]

Intact Vascular Announces Presentations at LINC 2019 Annual Meeting

WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a private medical device company committed to developing solutions for minimally invasive peripheral vascular procedures, today announced the schedule of key presentations to be featured at the annual Leipzig Interventional Course (LINC) in Leipzig, Germany on Tuesday, January 22nd and Wednesday, January 23rd. Intact Vascular’s Tack Endovascular […]

Microbot Medical Increases its Global IP Portfolio with Notice of Allowance from the European Patent Office

HINGHAM, Mass., Jan. 14, 2019 (GLOBE NEWSWIRE) — Microbot Medical Inc. (NASDAQ: MBOT), received a notification from the European Patent Office that it will grant a patent for Application No. 08738207, which covers the Company’s ViRob™ technology platform. Including this latest notification, the Company has 30 issued/allowed patents and 18 […]

InspireMD Announces the Distribution of CGuard™ Embolic Prevention System in South Africa

TEL AVIV, Israel, Jan. 14, 2019 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced that its novel CGuard EPS will be distributed by its local distribution partner, […]